dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Infant, Premature, Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (78.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moen, MD; Perry, CM; Wellington, K | 1 |
| Avila, E; Cook, L; Corbet, A; Edwards, K; Gerdes, J; Long, W; Puri, A; Rosenberg, A | 1 |
| Apere, H; Choukroun, ML; Demarquez, JL; Fayon, M; Galperine, RI; Guenard, H; Llanas, B | 1 |
| Bratlid, D; Farstad, T | 1 |
| Malathi, I; Ng, KC | 1 |
| Choukroun, ML; Demarquez, JL; Fayon, M; Galpérine, I; Guénard, H; Kays, C; Todd, DA | 1 |
| Beghetti, M; Berner, M; Hanquinet, S; Rimensberger, PC | 1 |
| Soll, RF; Suresh, GK | 1 |
| Bose, C; Bose, G; Corbet, A; Edwards, K; Prats, JG; Russell, L | 1 |
| Bosque, E; Goldman, SL; Lewis, K; McCann, E | 1 |
| Anday, E; Easa, D; Gong, A; LeBlanc, M; Long, W; Pauly, T; Pramanik, A; Sell, M; Stevenson, D; Walther, F | 1 |
| Derleth, D; Finer, N; Long, W; McMurray, B; Mullett, M; Peliowski, A; Sankaran, K; van Houten, J; Walker, D; Wold, D | 1 |
| Allen, A; Boros, S; Corbet, A; Edwards, K; Gerdes, J; Houle, L; Long, W; McMillan, D; Schiff, D; Vaughan, R | 1 |
| Bard, H; Chernick, V; Corbet, A; Cotton, R; Courtney, S; Long, W; McGuiness, G; Smyth, J; Walter, D; Watts, J | 1 |
1 review(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infant, Premature, Diseases
| Article | Year |
|---|---|
Lucinactant: in neonatal respiratory distress syndrome.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Animals, Newborn; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intercellular Signaling Peptides and Proteins; Peptides; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome; Surface Tension; Treatment Outcome | 2005 |
10 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infant, Premature, Diseases
| Article | Year |
|---|---|
Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
Topics: Bronchopulmonary Dysplasia; Cause of Death; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Enterocolitis, Pseudomembranous; Fatty Alcohols; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn | 1995 |
Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
Topics: Airway Resistance; Biological Products; Combined Modality Therapy; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature, Diseases; Lung Compliance; Male; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Positive-Pressure Respiration; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Mechanics; Time Factors | 1994 |
[Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature, Diseases; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1994 |
Respiratory mechanics before and after late artificial surfactant rescue.
Topics: Age Factors; Combined Modality Therapy; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiration, Artificial; Respiratory Mechanics | 1995 |
Results of laboratory surveillance of very low birth weight infants treated with a synthetic surfactant.
Topics: Blood; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants | 1992 |
Pulmonary mechanics in premature infants one month after treatment with synthetic surfactant.
Topics: Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Function Tests; Respiratory Mechanics | 1992 |
Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Double-Blind Method; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Analysis | 1992 |
Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Autopsy; Double-Blind Method; Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1992 |
Retrospective search for bleeding diathesis among premature newborn infants with pulmonary hemorrhage after synthetic surfactant treatment. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Double-Blind Method; Drug Combinations; Fatty Alcohols; Hemorrhagic Disorders; Humans; Infant, Newborn; Infant, Premature, Diseases; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Retrospective Studies | 1992 |
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Child; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Ventilator Weaning | 1991 |
3 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Infant, Premature, Diseases
| Article | Year |
|---|---|
Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Topics: Biological Products; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Hemodynamics; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Pulmonary Ventilation; Remission Induction; Respiration, Artificial; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Ventilation-Perfusion Ratio | 1995 |
First intention high-frequency oscillation with early lung volume optimization improves pulmonary outcome in very low birth weight infants with respiratory distress syndrome.
Topics: Drug Combinations; Fatty Alcohols; Female; High-Frequency Ventilation; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome | 2000 |
Current surfactant use in premature infants.
Topics: Drug Combinations; Fatty Alcohols; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Treatment Outcome | 2001 |